The 2023 worldwide total of 69 confirmed unprovoked cases is in line with the most recent five-year (2018-2022) average of 63 incidents annually. There were 14 confirmed shark-related fatalities this year, ten of which are assigned as unprovoked. This number is higher than the five-year annual global average of six unprovoked fatalities per year. Three of the unprovoked fatalities were due to bites from white sharks on surfers in Australia.
Annual fluctuations in shark-human interactions are expected. While the number of fatalities in 2023 was considerably higher than in 2022, there have been years in the past (2011) in which fatalities were also higher. The 2023 uptick in fatalities due to white sharks may reflect stochastic year-to-year variation, but it might also be the consequence of the increasing number of white sharks seen at aggregation sites near beaches that are popular with surfers (particularly in Australia). Year-to-year variability in oceanographic conditions influences the local abundance of sharks in the water, while weather patterns and economic conditions impact human activities along coastlines.
Consistent with long-term trends, the United States recorded the most unprovoked shark bites in 2023, with 36 confirmed cases. This is slightly lower than the 41 incidents recorded in 2022. The 36 cases represent 52% of the worldwide total.
New Caledonia reported three unprovoked bites, one of which was fatal. Egypt reported two unprovoked bites, including one fatality. The Bahamas and Mexico each reported one fatal unprovoked bite for 2023. Brazil reported three bites, none of which were fatal. South Africa reported two bites, neither of which were fatal. Costa Rica, Colombia, New Zealand, Seychelles, the Galapagos Islands and the Turks and Caicos Islands each reported single non-fatal incidents for 2023.
The total number of unprovoked shark bites worldwide remains extremely low. Fatalities saw an increase over the past year. Most of the fatalities in 2023 were due to white shark bites (three in Australia, one in California).
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Study selection: Prospective cohort studies and randomized trials of patients with a first episode of symptomatic VTE provoked by a transient risk factor and treated for at least 3 months were identified.
Data extraction: Number of patients and recurrent VTE during the 0- to 12-month and 0- to 24-month intervals after stopping therapy, study design, and provoking risk factor characteristics were extracted.
Data synthesis: Annualized recurrence rates were calculated and pooled across studies. At 24 months, the rate of recurrence was 3.3% per patient-year (11 studies, 2268 patients) for all patients with a transient risk factor, 0.7% per patient-year (3 studies, 248 patients) in the subgroup with a surgical factor, and 4.2% per patient-year (3 studies, 509 patients) in the subgroup with a nonsurgical factor. In the same studies, the rate of recurrence after unprovoked VTE was 7.4% per patient-year. The rate ratio for a nonsurgical compared with a surgical factor was 3.0 and for unprovoked thrombosis compared with a nonsurgical factor was 1.8 at 24 months.
Conclusions: The risk of recurrence is low if VTE is provoked by surgery, intermediate if provoked by a nonsurgical risk factor, and high if unprovoked. These risks affect whether patients with VTE should undergo short-term vs indefinite treatment.
Confabulation is a mysterious adjunct of amnesia. It remains unexplained why some patients invent untrue stories in response to questions (provoked confabulations) or even spontaneously with no apparent motivation (spontaneous confabulations). Hypothesized mechanisms range from a desire to fill gaps in memory to a loss of the temporal context in memory. We examined the mechanisms of confabulations in 16 amnesic patients. Patients were classified as spontaneous confabulators if they ever acted according to their confabulations. Provoked confabulations were measured as the number of intrusions in a verbal learning test. We found a double dissociation between the two types of confabulations, indicating that they represent different disorders rather than different degrees of the same disorder. Confabulating patients did not show an increased tendency to fill gaps in memory as measured by the number of fake questions concerning nonexistent items that they answered. Neither type of confabulation correlated with a failure to store new information as gauged with recognition tasks; pure information storage was even found to be normal in some patients. However, we found a positive correlation between several measures of verbal learning and verbal fluency with provoked, but not spontaneous, confabulations. In contrast, spontaneous, but not provoked, confabulations were associated with an inability to recognize the temporal order of stored information as measured by the comparison of two runs of a continuous recognition task. We suggest that provoked confabulations depend on an amnesic subject's search in his deficient memory and are the trade-off for increased item recollection. Spontaneous confabulations appear to be based on a failure to recognize the temporal order of stored information, resulting in erroneous recollection of elements of memory that do not belong together.
It is generally accepted that sleep deprivation contributes to seizures. However, it is unclear whether a seizure occurring in the setting of sleep deprivation should be considered as provoked or not and whether this is influenced by seizure type and etiology. This information may have an important impact on epilepsy diagnosis and management. We prospectively analyzed the influence of sleep deprivation on the risk of seizure recurrence in patients with first-ever unprovoked seizures and compared the findings with patients with first-ever provoked seizures. Of 1026 patients with first-ever unprovoked seizures, 204 (20%) were associated with sleep deprivation. While the overall likelihood of seizure recurrence was slightly lower in sleep-deprived patients with first-ever seizures (log-rank p=0.03), sleep deprivation was not an independent predictor of seizure recurrence on multivariate analysis. Seizure recurrence following a first-ever unprovoked seizure associated with sleep deprivation was far more likely than for 174 patients with a provoked first-ever seizure (log-rank p
Localised provoked vulval pain is the term used to describe pain at penetration of the vagina. There is also marked tenderness around the vaginal opening during a pelvic examination. This condition occurs in women of all ages and it is thought that approximately 15% of women (1 in 7) will experience this type of pain some time in their lifetimes. Other terms used in the past to describe this pain include vulval vestibulitis syndrome, superficial dyspareunia and vestibulodynia.
While the cause is not known researchers have found that this painful tissue has increased nerve endings and signs of inflammation. There are theories that chronic inflammation from frequent yeast infections, hormonal changes, poor sexual arousal or chronic skin conditions may trigger the pain. It is therefore likely that there are a combination of factors involved in the cause of localised provoked vulvodynia. It may be that there are a normal number of nerve endings that just fire too often.
Pain during vaginal penetration during sexual activity is the most common symptom experienced by most women with localised provoked vulvodynia. The pain is described as burning, searing, stinging, tearing, throbbing and occasionally itchy. Some women may experience pain for several hours or days after intercourse. Some women may also have pain when inserting a tampon or during a speculum examination during a routine gynaecological appointment.
The appearance of the vulva can vary which each woman. Some women with localised provoked vulvodynia may have redness at the vaginal opening, however for most women the vulva and the vestibule look entirely normal.
Localised provoked vulvodynia is a clinical condition which means there are no laboratory tests or imaging studies to confirm the diagnosis. It is important that you see a specialist who is experienced in the diagnosis and management of vulval conditions such as Dr Kliman. By taking a medical and surgical history and performing a physical examination Dr Kliman can rule out other reasons for the pain. A physical examination may involve using a Q-tip (cotton tipped swab stick). This is where Dr Kliman gently touches different parts of the vestibule (posterior area of the vaginal opening) with a Q-tip to determine if and where you have the pain. Other tests that may be included are swabs to rule out infection or a biopsy under local anaesthetic to exclude other serious skin conditions.
It is important to minimise irritation to the vulva and vagina avoiding soap, detergents and scented products is recommended. Bland unscented oil based lubricants are best for sexual activity. Cotton underwear is best; synthetic fabrics and tight clothing against the vulva should be avoided. Lignocaine in the form of a liquid gel or ointment can provide relief when it is applied directly to the vestibule. This can be used before sexual activity as a way to reduce the pain.
Many different treatment options have been tried for localised provoked vulvodynia (LPV). Some women experience a great sense of relief just knowing that the pain they are experiencing is real and has a name. With a supportive team that may include a spouse or a partner, gynaecologist, physical therapist (physiotherapist), sex therapist, pain specialist, and psychologist, most women will eventually have improvement of their symptoms. Often, different treatment options are combined to maximize the benefit.
795a8134c1